Artal International S.C.A.

CIK 00012181804 companiesLUXEMBOURG, N4

SEC Profile

Transactions

Companies

Filings

CIK

0001218180

Recent Transactions

44 trades

Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$8.55/sh+10,150→ 11,259,438 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$8.55/sh+10,150→ 11,259,438 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$6.85/sh+2,189,781→ 11,249,288 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$6.85/sh+2,189,781→ 11,249,288 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$6.85/sh+2,189,781→ 11,249,288 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$8.55/sh+10,150→ 11,259,438 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$6.85/sh+2,189,781→ 11,249,288 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$8.55/sh+10,150→ 11,259,438 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$6.85/sh+2,189,781→ 11,249,288 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$8.55/sh+10,150→ 11,259,438 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock, no par value per share
2011-05-26$83.66/sh−3,000,000→ 38,247,893 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock, no par value per share
2011-05-26$83.66/sh−3,000,000→ 38,247,893 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock, no par value per share
2011-05-26$83.66/sh−3,000,000→ 38,247,893 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock, no par value per share
2011-05-26$83.66/sh−3,000,000→ 38,247,893 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock, no par value per share
2011-05-26$83.66/sh−3,000,000→ 38,247,893 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock, no par value per share
2011-05-26$83.66/sh−3,000,000→ 38,247,893 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock, no par value per share
2011-05-26$83.66/sh−3,000,000→ 38,247,893 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock, no par value per share
2011-05-26$83.66/sh−3,000,000→ 38,247,893 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock, no par value per share
2011-05-26$83.66/sh−3,000,000→ 38,247,893 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+553,631.5→ 553,631 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−465,117→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−1,120,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+553,631.5→ 553,631 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−465,117→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−1,120,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+553,631.5→ 553,631 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+553,631.5→ 553,631 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−465,117→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−1,120,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+553,631.5→ 553,631 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−1,120,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−465,117→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−465,117→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−1,120,000→ 0 total

Companies

Recent Filings

Address

VALLEY PARK, 44, RUE DE LA VALLEE

LUXEMBOURG, N4, L-2661

View on SEC.gov